Organon CEO Kevin Ali to Resign
Organon faces leadership changes as CEO Kevin Ali resigns amid an investigation into improper sales practices involving Nexplanon.
Following an internal investigation, an audit committee discovered that select U.S. wholesalers were asked to purchase additional Nexplanon at the end of several quarters between 2022 and 2025.
While the findings to date do not necessitate a restatement or revision to any previously issued financial statements, the company is taking remedial actions to improve its financial controls and address any material weaknesses.
Organon CEO Kevin Ali, who has been with the company since its conception in 2021, intends to resign from his position.
Author's summary: Organon CEO Kevin Ali resigns amid investigation.
More News
- Eintracht Frankfurt Borussia Dortmund 28 10 2025 Live Score and Match Summary
- Al Nassr Al-Ittihad Jeddah 28 10 2025 Live Score and Match Summary
- Dodgers pitcher, EIU alum Will Klein wins World Series game 3
- Several elections pending to fill vacant legislative seats, starting Tuesday |
- Vance says troops will be paid as pressure builds to end shutdown
- Atalanta v AC Milan: Confirmed line-ups as Rossoneri look to end hosts' unbeaten start
- Pakistan vs South Africa, 1st T20I – Reeza Hendricks shines as South Africa secure 55-run win
- Post Malone Drops $1K in Tips at Grapevine Grill
- Looking back: Local ghost legends
- Nicole Kidman thriving while Keith Urban struggles after split